Skip to main content
. 2021 Jul 22;11:15000. doi: 10.1038/s41598-021-94603-9

Figure 1.

Figure 1

Comparison of the capture efficiency of EVs from serum between Tim4- and anti-CD9 antibody-based methods. Serum of normal donors (n = 6, 50 µL) was applied to a well of 96-well plate coated with Tim4 or anti-CD9 antibody (HI9a or A100-4). After washing, ALP-labeled antibody against an exosomal surface marker CD9 (a) or CD63 (b) was added to the well, followed by detection of chemiluminescence in the presence of ALP substrate. The signal intensity is expressed as a ratio to that obtained with Tim4. Data are shown by mean ± SD.